Human Papillomavirus Assay
Ongoing Challanges
The WHO estimates the global burden of cervical cancer will rise to 700,000 cases and 400,000 deaths by 2030. Over 95% of cervical cancers are due to HPV infection.
The high-risk genotypes HPV 16 and 18 cause approximately 70% of cervical cancers. HPV 6 and 11 cause the majority of anogenital warts.
The WHO strongly recommends HPV DNA detection as the primary screening test over VIA or cytology.
Product Overview
The EasyNAT® Human Papillomavirus Assay is a fast and sensitive DNA test to aid in the diagnosis of sexually transmitted HPV infections, specifically detecting types 6, 11, 16, and 18.
Results available within 51 minutes
Designed to provide an accurate LOD: 1000 copies/mL
Aids in the early diagnosis of HPV to help prevent potential HPV-attributable cancers.
Clinical Value
A fast and sensitive DNA test to aid in diagnosing sexually transmitted HPV infections.
Detects and distinguishes between HPV types 6, 11, 16, and 18.
Offers early identification of HPV infection, helping to prevent potential HPV-attributable cancers.
